Booz Allen Hamilton (NYSE: BA) has acquired Boston-based population health informatics company Epidemico for an undisclosed sum in a push to further develop analytics offerings in population health.
Karen Dahut, a Booz Allen executive vice president, said Wednesday that the acquisition is “aligned to Booz Allen’s Innovation agenda, adding a creative and successful startup to our firm.”
Epidemico — a commercial spinoff of Boston Children’s Hospital, Harvard Medical School and the Massachusetts Institute of Technology — builds software to analyze multiple health data sets for customers in the government, life science and financial sectors, including Fortune 500 companies based in the U.S. and internationally.
Epidemico focuses its work on data acquisition and analysis technologies for continuous monitoring and consumer engagement for aspects of population health such as disease outbreaks, drug safety supply chain vulnerabilities and more.
The Food and Drug Administration, Centers for Disease Control and Prevention and Department of Homeland Security use Epidemico’s cloud-based tools.
Dahut, who also leads Booz Allen’s Strategic Innovation Group, said Epidemico’s products and “popular social media feeds, will also accelerate our efforts to develop alternative revenue streams for Booz Allen.”
“(The acquisition is) a critical first step in our broader strategy of growth through organic and inorganic investment – building a full portfolio of analytic platforms and solutions to address the critical need for improved analytics and data science across our client base, ” said Fred Blackburn, a Booz Allen EVP and head of the firm’s NextGen Analytics program.
“We believe that the health analytics space is the ideal place to begin executing that strategy, given its obvious importance to the population, as well as the associated business opportunities.”
Epidemico’s HealthMap software tool is designed to track more than 200 infectious diseases worldwide in 15 different languages.
“The addition of Epidemico’s analytic capabilities to our data science team builds on the firm’s broader strategy of expanding its engineering and technology expertise to respond to the changing demands of government and commercial clients seeking more cost-effective and innovative solutions, ” said Horacio Rozanski, Booz Allen president and chief operating officer.